Back
Esperion Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
56
ESPR
Esperion Therapeutics, Inc.
Last Price:
$3.48
Seasonality Move:
13.7%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and ESPR is experiencing slight selling pressure.
Esperion Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.48 | Buy |
| 20-day SMA: | 3.42 | Buy |
| 50-day SMA: | 3.56 | Sell |
| 200-day SMA: | 2.42 | Buy |
| 8-day EMA: | 3.42 | Buy |
| 20-day EMA: | 2.76 | Buy |
| 50-day EMA: | 1.63 | Buy |
| 200-day EMA: | 0.51 | Buy |
Esperion Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.78 | Buy |
| Relative Strength Index (14 RSI): | 51.37 | Buy |
| Chaikin Money Flow: | -1122641 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.16 - 3.54) | Buy |
| Bollinger Bands (100): | (2.84 - 3.74) | Buy |
Esperion Therapeutics, Inc. Technical Analysis
| Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 17 | Feb 18 | Feb 19 | Feb 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Esperion Therapeutics, Inc. Stock
Is Esperion Therapeutics, Inc. Stock a Buy?
-
Esperion Therapeutics, Inc. share price is 3.48 while ESPR 8-day simple moving average is 3.48, which is a Buy signal.
-
The stock price of ESPR is 3.48 while Esperion Therapeutics, Inc. 20-day SMA is 3.42, which makes it a Buy.
-
Esperion Therapeutics, Inc. 50-day simple moving average is 3.56 while ESPR share price is 3.48, making it a Sell technically.
-
ESPR stock price is 3.48 and Esperion Therapeutics, Inc. 200-day simple moving average is 2.42, creating a Buy signal.
ESPR Technical Analysis vs Fundamental Analysis
Buy
56
Esperion Therapeutics, Inc. (ESPR)
is a Buy
Is Esperion Therapeutics, Inc. a Buy or a Sell?
-
Esperion Therapeutics, Inc. stock is rated a BuyThe current Esperion Therapeutics, Inc. [ESPR] share price is $3.48. The Score for ESPR is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Esperion Therapeutics, Inc. Stock Info
Market Cap:
831.9M
Price in USD:
3.48
Share Volume:
2.5M
Esperion Therapeutics, Inc. 52-Week Range
52-Week High:
4.18
52-Week Low:
0.69
Buy
56
Esperion Therapeutics, Inc. (ESPR)
is a Buy
Esperion Therapeutics, Inc. Share Price Forecast
-
What is the Esperion Therapeutics, Inc. stock price today?The Esperion Therapeutics, Inc. stock price is 3.48 USD today.
-
Will ESPR stock go up or go down?Esperion Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Esperion Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Esperion Therapeutics, Inc. is not overvalued.
Is Esperion Therapeutics, Inc. Stock a Buy?
-
Esperion Therapeutics, Inc. share price is 3.48 while ESPR 8-day exponential moving average is 3.42, which is a Buy signal.
-
The stock price of ESPR is 3.48 while Esperion Therapeutics, Inc. 20-day EMA is 2.76, which makes it a Buy.
-
Esperion Therapeutics, Inc. 50-day exponential moving average is 1.63 while ESPR share price is 3.48, making it a Buy technically.
-
ESPR stock price is 3.48 and Esperion Therapeutics, Inc. 200-day simple moving average is 0.51, creating a Buy signal.
Fundamental Analysis of Esperion Therapeutics, Inc.
Is Esperion Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.38 per share.
Technical Analysis of Esperion Therapeutics, Inc.
Should I short Esperion Therapeutics, Inc. stock?
-
ESPR Moving Average Covergence Divergence (MACD) indicator is 0.78, suggesting Esperion Therapeutics, Inc. is a Buy
-
Esperion Therapeutics, Inc. Relative Strength Index (RSI) is 51.37, which suggest Esperion Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Esperion Therapeutics, Inc. is (3.16 - 3.54), which suggest Esperion Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Esperion Therapeutics, Inc. is (2.84 - 3.74), which suggest Esperion Therapeutics, Inc. is a Buy
* Esperion Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.